Antiproliferative effect of 4-thiouridylate on OCM-1 uveal melanoma cells

European Journal of Ophthalmology

Volumn 16, Issue 5, 2006, Pages 680-685

  Kemeny Beke A ^a   Berenyi E ^a   Facsko A ^a   Damjanovich, J ^a   Horvath A ^a   Bodnar A ^a   Berta, A ^a   Aradi, Janus ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Antitumor; Nucleotide; OCM 1; Uveal melanoma

Indexed keywords

4 THIOURIDINE PHOSPHATE; CASPASE 9; URIDINE PHOSPHATE;

APOPTOSIS; ARTICLE; CELL VIABILITY; DRUG EFFECT; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MICROSCOPY; PRIORITY JOURNAL; UVEA MELANOMA;

EID: 33845335788     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210601600504     Document Type: Article

References (18)

1. Albert DM, Niffenegger AS, Willson JK. Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol 1992; 36: 429-38.
2. Zierhut M, Streilein JW, Schreiber H, Jager MJ, Ruiter D, Ksander BR. Immunology of ocular tumours. Immunol Today 1999; 20: 482-5.
3. Harbour JW, Char DH, Kroll S, Quivey JM, Castro J. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma. Ophthalmology 1997; 104: 1785-92.
4. Heine B, Coupland SE, Kneiff S, et al. Telomerase expression in uveal melanoma. Br J Ophthalmol 2000; 84: 217-23.
5. Repp AC, Mayhew ES, Howard K, Alizadeh K, Niederkorn JY. Role of fas ligand in uveal melanoma-induced liver damage. Graefes Arch Clin Exp Ophthalmol 2001; 239: 752-8.
6. Walker TM, Van Ginkel PR, Gee RL, et al. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch Ophthalmol 2002; 120: 1719-25.
7. Bene L, Bodnár A, Damjanovich S, et al. Membrane topography of HLA I, HLA II, and ICAM-1 is affected by IFN-gamma in lipid rafts of uveal melanomas. Biochem Biophys Res Commun 2004; 17: 678-83.
8. Labialle S, Dayan G, Gambrelle J, et al. Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives. Melanoma Res 2005; 15: 257-66.
9. Klisovic DD, Klisovic MI, Effron D, Liu S, Marcucci G, Katz SE. Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma. Melanoma Res 2005; 15: 147-53.
10. Kemény-Beke Á, Aradi J, Damjanovich J, et al. Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine. Cancer Lett 2006; 237: 67-75.
11. 35. Virology 2005; 334: 214-23.
12. Horváth A, Aradi J. Advantages of sodium perchlorate solution as mobile phase for purification of synthetic oligonucleotides by anion exchange chromatography. Anal Biochem 2005; 338: 341-3.
13. Kan-Mitchell J, Mitchell MS, Rao N, Liggett PE. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci 1989; 30: 829-34.
14. Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 1986; 94: 57-63.
15. Zhu N, Wang Z. An assay for DNA fragmentation in apoptosis without phenol/chloroform extraction and ethanol precipitation. Anal Biochem 1997; 246: 155-8.
16. Simuth J, Scheit KH, Gottschalk EM. The enzymatic synthesis of poly 4-thiouridylic acid by polynucleotide phosphorylase from Escherichia coli. Biochim Biophys Acta 1970; 204: 371-80.
17. Mandel R, Ryser HJ-P, Ghani F, Wu M, Peak D. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci USA 1993; 90: 4112-16.
18. Terada K, Manchikalapudi P, Noiva R, Jauregui HO, Stockert RJ, Schilsky ML. Secretion, surface localization, turnover, and steady state expression of protein disulfide isomerase in rat hepatocytes. J Biol Chem 1995; 270: 20410-6.